2018-02-27 BR&R Conf Call

From HL7Wiki
Jump to navigation Jump to search

Attendees

  • Ed Helton (Co-Chair)
  • Boris Brodsky (Co-Chair)
  • Myron Finseth (Co-chair, scribe)
  • Nagesh Basham
  • Julia Chen
  • Julie Evans
  • Bill Friggle
  • Jose Galvez
  • Smita Hastak
  • Catherine Hosage Norman
  • Ginny Hussong
  • Wendy Ver Hoef
  • Shifu Zhao
  • Norman Gregory
  • Robinette Renner
  • Ulrike Wagner
  • Jim Rogers
  • Gary Saner

Agenda Items and notes

1. Minutes Approval

  • January WG Meeting minutes approved on February 13, 2018 (MF)

Motion to approve: Jose Galvez Second: Julie Evans

2. HL7 Ballot

  • The FDA withdrew the SPL R9 and CPM R5 standards (supports PQ/CMC requirements) from the May ballot. The WG approved removal of SPL R9 and CPM R5 from the May ballot. There might be an opportunity to ballot these two standards in Sept 2018 or later.
  • BRIDG will be on the May ballot. New semantics were added in support of Common Data Model Harmonization (CDMH) project and some draft semantics in support of DICOM Structured Pathology Report. The updated model needs to be re-balloted for acceptance by the HL7 community.

The WG voted to withdraw the SPL/CPM on the May ballot, and to INCLUDE the BRIDGE on the May ballot. The vote was unanimous. Catherine Hosage Norman motioned to approve. Jose Galvez second.

2. Action items handling

  • TBD

3. PSS Review and Approval

3.1 Patient Reported Outcomes PSS [1]

  • Dragon motioned to approve the PSS. Jose second the motion. The PSS passed. Bill Friggle asked if someone from BR&R could follow the project and report back to the WG as necessary to report progress or helpful notes. Group agreed that would be a good idea. Bill will be the person following this project.

3.2 SPL r9 (PQ/CMC) PSS

  • The SPL R9 and CPM R5 standard were removed from the May ballot cycle. These two standards could be submitted for the September ballot.

3.3 Patient Outcomes Reporting

4. FHIR

4.1 FHIR Tracker Items

  • Look at outstanding items

4.2 IDMP Related Models

  •  ???

4.3 Lab model in collaboration with TransCelerate

5. Action Item List

  • Nothing at this time

6. AOB

  •  ???